MedPath

Study of lactate dehydrogenase and platelets in patients with Immune thrombocytopenic purpura

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: D899- Disorder involving the immune mechanism, unspecified
Registration Number
CTRI/2023/01/048988
Lead Sponsor
Kasturba Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Newly diagnosed ITP cases.

Secondary ITP, including :

-Autoimmune syndromes

-HIV, hepB and C

-Immunodeficiency syndromes

-Vaccine induced

Exclusion Criteria

-Hemolytic anemias

-Vitamin B12 and folate deficiency

-Drug induced

-Active infections

-Underlying CLD

-Drug induced

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of Platelet indices and LDH and studying the association with severity of ITPTimepoint: Assessment of Platelet indices and LDH and studying the association with severity of ITP at the time of admission (before starting treatment)
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath